These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16 related articles for article (PubMed ID: 3835207)
1. Blood dapsone levels in leprosy patients treated with acedapsone. George J; Balakrishnan S Indian J Lepr; 1986; 58(3):401-6. PubMed ID: 3794408 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of dapsone and amino acid prodrugs of dapsone. Pochopin NL; Charman WN; Stella VJ Drug Metab Dispos; 1994; 22(5):770-5. PubMed ID: 7835230 [TBL] [Abstract][Full Text] [Related]
3. Plasma dapsone and its metabolite monoacetyldapsone levels in leprotic patients. Garg SK; Kumar B; Bakaya V; Lal R; Shukla VK; Kaur S Int J Clin Pharmacol Ther Toxicol; 1988 Nov; 26(11):552-4. PubMed ID: 3243659 [TBL] [Abstract][Full Text] [Related]
4. Acedapsone treatment of leprosy patients: response versus drug disposition. Peters JH; Murray JF; Gordon GR; Levy L; Russell DA; Scott GC; Vincin DR; Shepard CC Am J Trop Med Hyg; 1977 Jan; 26(1):127-36. PubMed ID: 842774 [TBL] [Abstract][Full Text] [Related]
5. Armadillo as a model for studying chemotherapy of leprosy: preliminary studies. Dhople AM Indian J Lepr; 1986; 58(1):19-28. PubMed ID: 3745995 [TBL] [Abstract][Full Text] [Related]
6. Chemical drug delivery systems: I. Preparation and evaluation of prodrugs of dapsone. Kulkarni VM; Mishra DS Indian J Lepr; 1985; 57(4):756-62. PubMed ID: 3835207 [TBL] [Abstract][Full Text] [Related]
7. Patient compliance with dapsone administration in leprosy. Huikeshoven H Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):228-58. PubMed ID: 7024150 [No Abstract] [Full Text] [Related]